Janice Castillo

机构：Equinor (United Kingdom)

发表论文 10 篇 · 总被引 1354 次 · h-index 6

代表论文

Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity (2015 · New England Journal of Medicine · 被引 1047)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial Demonstrating Reversal Of Rivaroxaban-Induced Anticoagulation In Healthy Subjects By Andexanet Alfa (PRT064445), An Antidote For Fxa Inhibitors (2013 · Blood · 被引 115)
Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet alfa (2017 · Blood Advances · 被引 76)
A phase 2 PK/PD study of andexanet alfa for reversal of rivaroxaban and edoxaban anticoagulation in healthy volunteers (2020 · Blood Advances · 被引 42)
455 (2014 · Critical Care Medicine · 被引 39)
ANNEXATM-R: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, DEMONSTRATING REVERSAL OF RIVAROXABAN-INDUCED ANTICOAGULATION IN OLDER SUBJECTS BY ANDEXANET ALFA (PRT064445), A UNIVERSAL ANTIDOTE FOR FACTOR XA (FXA) INHIBITORS (2015 · Journal of the American College of Cardiology · 被引 26)